These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35681095)

  • 1. Impacts of exposure to topical calcineurin inhibitors on metabolism in vitiligo infants.
    Hu W; Lin F; Lei J; Xu AE
    Pediatr Res; 2023 Feb; 93(3):661-665. PubMed ID: 35681095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study.
    Hu W; Xu Y; Ma Y; Lei J; Lin F; Xu AE
    Clin Drug Investig; 2019 Dec; 39(12):1233-1238. PubMed ID: 31522334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study.
    Seneschal J; Duplaine A; Maillard H; Passeron T; Andreu N; Lassalle R; Favary C; Droitcourt C; Taïeb A; Ezzedine K
    J Invest Dermatol; 2021 Jul; 141(7):1728-1734. PubMed ID: 33549606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of Tacrolimus 0.1% ointment and Tacrolimus 0.1% plus topical pseudocatalase/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial.
    Alshiyab DM; Al-Qarqaz FA; Muhaidat JM; Alkhader YS; Al-Sheyab RF; Jafaar SI
    J Dermatolog Treat; 2022 Feb; 33(1):146-149. PubMed ID: 32048900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR; Vander Straten MR; Korman NJ
    Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
    Dayal S; Sahu P; Gupta N
    Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Tacrolimus Ointment Alone versus in Combination with Microneedling for Refractory Stable Vitiligo.
    Kiran A; Khan S; Ahmed N; Ali M
    J Coll Physicians Surg Pak; 2024 May; 34(5):514-517. PubMed ID: 38720208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
    Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
    J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.
    Sisti A; Sisti G; Oranges CM
    An Bras Dermatol; 2016 Apr; 91(2):187-95. PubMed ID: 27192518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial.
    Pazyar N; Hatami M; Yaghoobi R; Parvar SY; Radmanesh M; Hadibarhaghtalab M
    J Cosmet Dermatol; 2023 May; 22(5):1513-1520. PubMed ID: 36718813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
    Tanghetti EA
    Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial.
    Alshiyab D; Ba-Shammakh SA; Al-Fakih A; Tashman O; Sarakbi D; Al-Qarqaz F; Muhaidat J; Atwan A; Cork MJ
    J Dermatolog Treat; 2024 Dec; 35(1):2296851. PubMed ID: 38124534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
    Abd-Elazim NE; Yassa HA; Mahran AM
    J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non-segmental vitiligo.
    Zartab H; Aflatoonian M; Shamsi-Meymandi S; Pardakhty A; Isazadeh A; Firooz A; Amiri R
    J Cosmet Dermatol; 2024 Jun; 23(6):2103-2108. PubMed ID: 38348697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
    Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
    Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.